Founded in 2011, Samabriva is a biotechnology company which has developed a disruptive bioproduction platform gathering the best of plants and usual biomanufacturing in fully controlled, affordable, scalable, sustainable and animal/virus-free bioprocesses currently being implemented by industrial companies for the production of high-value molecules (recombinant proteins and secondary metabolites). Samabriva has developed a fully documented and controlled process from the sequence design to large scale bioproduction. This innovative bioproduction system allows complex molecules production for therapeutic, diagnostic or cosmetic area and proposes to leverage its capabilities to meet customers’/partners’ needs. The technology is a plant-based expression system which uses a natural phenomenon to develop stable & high producer root clones cultured in confined large scale bioreactors.